On September 20, 2023, Forte Biosciences Inc announced that it held its 2023 annual meeting of shareholders on September 19, 2023 and declared the voting Results. Accordingly, nominations made by Camac Partners LLC to appoint Michael G Hacke and Chris McIntyre to the Company board were not appointed, nominations made by the Company to appoint Lawrence Eichenfield and Paul A. Wagner were appointed by the shareholders of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7109 USD | -1.26% | -4.10% | -13.48% |
03-18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-05 | Camac Partners Provides Information to Shareholders | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.48% | 25.87M | |
+10.44% | 107B | |
+0.82% | 106B | |
+6.72% | 23.47B | |
-13.89% | 21.9B | |
-6.64% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Declaration of Voting Results by Forte Biosciences